Table 1.
Clinicopathological characteristics of 90 female dogs with mammary tumors enrolled in the overall survival analysis.
| CMT | Benign Mammary Tumor (BMT) | Malignant Mammary Tumor (MMT) | ||||
|---|---|---|---|---|---|---|
| Group | Case Number (%) | Median (Range) Age, Year |
Median (Range) B.W., kg |
Case Number (%) | Median (Range) Age, Year |
Median (Range) B.W., kg |
| Total | 20 (100) | 8.4 (3–16) | 5.4 (2.45–38) | 70 (100) | 10 (1–16) | 7.4 (1.7–44.6) |
| Breed | ||||||
| Pedigree | 18 (90) | 8.2 (3–15) | 5.4 (2.45–38) | 55 (78.6) | 9 (1–16) | 5.9 (1.7–38) |
| Mixed | 2 (10) | 14.5 (13–16) | 18.4 (13.4–23.4) | 15 (21.4) | 12 (8–16) | 15.3 (2.4–44.6) |
| Neuter status | ||||||
| Yes | 6 (30) | 10 (9–15) | 7.2 (2.45–19.4) | 29 (41.4) | 12 (3.5–16) | 11.4 (2.1–44.6) |
| No | 14 (70) | 7.9 (3–16) | 5.5 (2.7–38) | 41 (58.6) | 8.5 (1–13) | 5.6 (1.7–30.4) |
| Clinical stage 1 | ||||||
| I | - | - | 34 (48.6) | 9 (1–16) | 5.05 (1.7–20.6) | |
| II | - | - | - | 9 (12.9) | 11 (8–16) | 8.5 (2.1–44.6) |
| III | - | - | 16 (22.8) | 12 (8–16) | 11.8 (2.36–29.8) | |
| IV | 7 (10) | 13 (8–15) | 10.8 (4.2–38) | |||
| V | - | - | 4 (5.7) | 11 (3.5–11) | 19.7 (12.9–26.4) | |
| Metastasis | - | - | ||||
| No (I/II/III) | - | - | 59 (84.3) | 10 (1–16) | 6.9 (1.7–44.6) | |
| Yes (IV/V) | - | - | 11 (15.7) | 11 (3.5–15) | 15.6 (4.2–38) | |
1 Clinical stage was determined according to the modified WHO classification for domestic animals.